Cetrelimab
Cetrelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Cetrelimab is under investigation in clinical trial NCT03547037 (A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers).
| Trade Name | Cetrelimab |
| Generic | Cetrelimab |
| Cetrelimab Other Names | Cetrelimab, JNJ-63723283 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Cetrelimab
